
    
      The patients enrolled will received 4-6 cycles chemotherapy at first.Then, radical
      radiotherapy for nasopharyngeal tumors and local treatments for oligometastatic lesions will
      assigned to those patients. The efficacy and side-effect will be evaluated and analyzed.
    
  